Baclofen toxicity

Background

  • Baclofen is a synthetic derivative of GABA used to reduce spasticity in conditions such as multiple sclerosis and cerebral palsy, or to reduce muscular spasm in lower back pain.
  • At therapeutic doses, baclofen acts as a GABA-B receptor agonist in the spinal cord, causing inhibition of muscular tone.
  • At higher doses, baclofen loses selectivity and can cause sedation.
  • Primarily (80%) excreted by the kidneys
    • Dosage must be reduced in renal dysfunction and should be avoided with GFR < 30 mL/min/1.73 m2.
    • Patients on chronic therapy may become toxic with new AKI.

Clinical Features

  • Nausea and vomiting
  • Drowsziness
  • Delirium
  • Seizures
  • Coma
  • Respiratory compromise
  • Hypothermia

Differential Diagnosis

Sedative/hypnotic toxicity

Evaluation

  • Diagnosis of exclusion

Management

  • Activated charcoal for recent ingestion
  • Supportive care:
    • IV fluids, respiratory care
    • Vasopressors for persistent hypotension
    • Benzodiazepines for seizures
  • Hemodialysis for very severe toxicity

Disposition

See Also

References

  • Jung, M. “Baclofen Overdoses”. Maryland Poison Center, University of Maryland School of Pharmacy. www.mdpoison.com Accessed April 29th, 2014.
  • Nicola Y Leung, Ian M Whyte, Geoffrey K Isbister Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas: 2006, 18(1);77-82